Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

ANGO stock hub

AngioDynamics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ANGOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

466.8M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ANGO

In the news

Latest news · ANGO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-17.5

P25 -105.6P50 -46.5P75 -3.1

ROIC-13.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ANGO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

226

Groups with data

Currency

USD

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001275187
Company name	AngioDynamics, Inc.
Country	United States
Country code	US
Cusip	03475V101
Employees	675
Employees Change	-73%
Employees Change Percent	-9.76
Enterprise value	$440.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Instruments & Supplies
IPO Date	2004-05-27
Isin	US03475V1017
Last refreshed	2026-05-10
Market cap	$466.8M
Market cap category	Small-Cap
Price	$11.2
Price currency	USD
Rev Per Employee	464,777.78x
Sector	Healthcare
Sic	3841
Symbol	ANGO
Website	https://www.angiodynamics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.72%
EV Sales Forward	1.33x
EV/FCF	293.03x
EV/Sales	1.4x
FCF yield	0.32%
P/B ratio	2.69x
P/S ratio	1.49x
PS Forward	1.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-6.52%
EBITDA Margin	-0.21%
FCF margin	0.48%
Gross margin	54.3%
Gross Profit	$170.3M
Gross Profit Growth	10.61%
Gross Profit Growth Q	6.75%
Gross Profit Growth3 Y	-0.77%
Gross Profit Growth5 Y	3.42%
Net Income	$-31.4M
Net Income Growth Years	1%
Pretax Margin	-10%
Profit Margin	-10%
Profit Per Employee	$-46,499
ROA	-4.68
Roa5y	-3.16
ROCE	-10.51
ROE	-17.47
Roe5y	-21.38
ROIC	-13.94

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-1.06%
Cagr15y	-2.2%
Cagr1y	27.73%
Cagr20y	-4.67%
Cagr3y	8.7%
Cagr5y	-14.22%
EPS Growth Years	1
FCF Growth5 Y	-31.17%
OCF Growth10 Y	-19.07%
OCF Growth5 Y	-22.37%
Revenue Growth	10.73x
Revenue Growth Q	8.92x
Revenue Growth Quarters	4x
Revenue Growth Years	0x
Revenue Growth3 Y	-2.13x
Revenue Growth5 Y	2.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.15
Assets	$260.7M
Cash	$37.8M
Current Assets	$155.6M
Current Liabilities	$66.1M
Debt	$11.4M
Debt EBITDA	$6.41
Debt Equity	$0.07
Debt FCF	$7.58
Equity	$173.4M
Interest Coverage	-68.17
Liabilities	$87.3M
Long Term Assets	$105.1M
Long Term Liabilities	$21.3M
Net Cash	$26.4M
Net Cash By Market Cap	$5.66
Net Cash Growth	-22.45%
Net Debt Equity	$-0.15
Net Debt FCF	$-17.58
Tangible Book Value	$107.9M
Tangible Book Value Per Share	$2.59
WACC	6.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.35
Inventory Turnover	2.36
Net Working Capital	$53.4M
Quick ratio	1.26
Working Capital	$89.5M
Working Capital Turnover	$3.41

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.55%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-10.11%
1Y total return	27.71%
200-day SMA	11.06
3Y total return	28.44%
50-day SMA	10.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-53.55%
All Time High	32
All Time High Change	-65%
All Time High Date	2021-11-05
All Time Low	5.26
All Time Low Change	112.93%
All Time Low Date	2024-03-25
ATR	0.39
Beta	0.37
Beta1y	0.57
Beta2y	0.19
Ch YTD	-12.77
High	11.39
High52	13.99
High52 Date	2025-12-04
High52ch	-19.94%
Low	11.1
Low52	8.36
Low52 Date	2025-08-08
Low52ch	33.97%
Ma50ch	3.72%
Premarket Change Percent	-2.4
Premarket Price	$11
Premarket Volume	100
Price vs 200-day SMA	1.3%
RSI	56.01
RSI Monthly	52.87
RSI Weekly	51.85
Sharpe ratio	0.68x
Sortino ratio	1.09
Total Return	-1.55%
Tr YTD	-12.77
Tr15y	-28.39%
Tr1m	15.46%
Tr1w	0.36%
Tr3m	6.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.11
Earnings Revenue Estimate	77,012,002x
Earnings Revenue Estimate Growth	6.96x
Operating Income	$-20.5M
Operating margin	-6.52
Price target	$18
Price Target Change	$60.71

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	34,967,092%
Float Percent	83.89%
Net Borrowing	-368,000
Shares Insiders	9.33%
Shares Institutions	85.37%
Shares Out	41,682,097
Shares Qo Q	0.13%
Shares Yo Y	1.55%
Short Float	6.18%
Short Ratio	3.97
Short Shares	5.18

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-10.2M
Average Volume	355,273.6x
Bv Per Share	4.16
CAPEX	$-2.9M
Ch10y	-10.11
Ch15y	-28.39
Ch1m	15.46
Ch1w	0.36
Ch1y	27.71
Ch20y	-61.58
Ch3m	6.06
Ch3y	28.44
Ch5y	-53.55
Ch6m	-6.82
Change	-0.62%
Change From Open	-1.23
Close	11.27
Days Gap	0.62
Depreciation Amortization	19,791,000
Dollar Volume	3,260,308.8
Earnings Date	2026-04-02
Earnings Time	bmo
EBIT	$-20.5M
EBITDA	$-659,000
EPS	$-0.76
F Score	5
FCF	$1.5M
FCF EV Yield	0.34x
FCF Per Share	$0.04
Financing CF	-5,098,000
Fiscal Year End	May
Founded	1,988
Income Tax	$12,000
Investing CF	-7,302,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-02
Last Report Date	2026-02-28
Last Split Type	Never
Last10k Filing Date	2025-07-18
Ma150	11.45
Ma150ch	-2.19%
Ma20	10.88
Ma20ch	2.94%
Net CF	-6,950,000
Next Earnings Date	2026-07-14
Open	11.34
Optionable	Yes
P FCF Ratio	310.6
P OCF Ratio	105
Position In Range	34.48
Ppne	34,550,000
Pre Close	11.27
Price Date	2026-05-08
Ptbv Ratio	4.33
Relative Volume	0.82x
Revenue	313,725,000x
SBC By Revenue	3.72x
Share Based Comp	11,686,000
Tax By Revenue	0x
Tr20y	-61.58%
Tr6m	-6.82%
Us State	New York
Volume	291,099
Z Score	1.88

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ANGO pay a dividend?

Capital-return profile for this ticker.

Performance

ANGO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ANGO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+85.4%

Float: +83.9% of shares outstanding

Insider ownership

+9.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ANGO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.0

Neutral momentum band

Price vs 200-day MA

+1.3%

50/200-day relationship not available

Beta (5Y)

0.37

Less volatile than the market

Sharpe ratio

0.68

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ANGO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ANGO stock rating?

AngioDynamics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ANGO analysis?

The full report lives at /stocks/ANGO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ANGO?

The latest report frames ANGO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ANGO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.